V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014507 | 220009087 | 1.71 | 87.4 | Curative (C) | null | 2015-09-01 | Cytarabine intrathecal | N | N | 220034195 | CYTARABINE INTRATHECAL |
| 220014508 | 220009088 | 1.64 | 66 | Palliative (P) | 2018-06-24 | 2018-07-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220034210 | CARBOPLATIN + PACLITAXEL |
| 220014509 | 220014848 | 1.74 | 66.6 | Disease modification (D) | 2014-12-18 | 2014-12-18 | UKALL14- Ph 1 Induction | 02 | N | 220034214 | ECX |
| 220014510 | 220009090 | 1.86 | null | Curative (C) | 2016-08-29 | 2016-08-29 | CARBOPLATIN + PACLITAXEL | 2 | N | 220034218 | CARBOPLATIN + PACLITAXEL |
| 220014512 | 220009094 | 1.7 | 0 | Palliative (P) | 2017-03-24 | 2017-03-30 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 220034228 | GEMTUZUMAB OZOGAMICIN |
| 220014515 | 220009097 | null | 70.3 | Palliative (P) | 2014-02-03 | 2014-02-03 | UKALL14- Ph 2 Induction | Y | null | 220034249 | GEMCARBO |
| 220014516 | 220009097 | 1.6 | 58 | Palliative (P) | 2015-08-13 | 2015-08-13 | Cytarabine intrathecal | N | N | 220034249 | CYTARABINE INTRATHECAL |
| 220014517 | 220009098 | null | 93.8 | Curative (C) | 2013-05-26 | 2014-09-30 | Cytarabine intrathecal | N | N | 220034259 | CYTARABINE INTRATHECAL |
| 220014518 | 220009099 | 1.54 | 66.2 | null | null | 2014-09-11 | Clofarabine + Cytarabine | N | N | 220034259 | DOCETAXEL |
| 220014519 | 220009101 | 1.77 | 94 | Palliative (P) | 2017-04-26 | 2017-05-04 | IDARUBICIN | 2 | N | 220034266 | IDARUBICIN |
| 220014520 | 220009103 | null | 88.4 | Curative (C) | 2017-11-24 | 2017-11-30 | PONATINIB | N | N | 220034268 | ECX |
| 220014521 | 220014856 | 1.7 | null | Palliative (P) | 2014-11-18 | 2014-11-18 | Carboplatin + Etoposide iv&po | N | N | 220034274 | CARBOPLATIN + ETOPOSIDE |
| 220014522 | 220014856 | 1.86 | 73.25 | Palliative (P) | 2016-03-05 | 2016-04-02 | Clofarabine + Cytarabine | 2 | N | 220034274 | CLOFARABINE + CYTARABINE |
| 220014523 | 220014856 | 1.6 | 73.9 | Palliative (P) | 2017-03-12 | 2017-03-14 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220034274 | CARBOPLATIN + PACLITAXEL |
| 220014524 | 220009106 | 1.86 | 90.8 | Curative (C) | 2016-07-01 | 2016-07-08 | UKALL14- Ph 2 Induction | 02 | N | 220034283 | CLOFARABINE + CYTARABINE |
| 220014525 | 220009107 | 1.74 | 61.1 | Palliative (P) | null | 2013-12-15 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220034288 | CLOFARABINE + CYTARABINE |
| 220014528 | 220009108 | 1.58 | 61 | Palliative (P) | 2015-01-31 | 2015-01-31 | CISPLATIN + GEMCITABINE | 2 | N | 220034296 | UKALL2014 |
| 220014529 | 220014859 | 1.67 | 70 | null | 2014-11-11 | 2015-02-11 | GEMTUZUMAB OZOGAMICIN | 02 | N | 220034301 | IRINOTECAN + MDG |
| 220014530 | 220018112 | 1.61 | 68 | Palliative (P) | 2016-01-31 | 2016-01-31 | PONATINIB | N | N | 220034302 | ECX |
| 220014531 | 220009110 | null | null | Curative (C) | 2017-01-05 | 2017-01-13 | Fludarabine + Melphalan RIC Allo | N | N | 220034303 | IRINOTECAN + MDG |
| 220014532 | 220009111 | 1.82 | null | Palliative (P) | 2013-12-26 | 2014-01-25 | Mitox + Tretinoin Spanish Course 3 | N | null | 220034305 | MITOXANTRONE |
| 220014533 | 220014860 | 1.94 | 98 | null | 2016-01-25 | 2016-02-08 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | N | 220034322 | ALEMTUZUMAB |
| 220014534 | 220009113 | 1.84 | 75.6 | Palliative (P) | null | 2013-12-01 | Cytarabine intrathecal | N | N | 220034334 | CYTARABINE INTRATHECAL |
| 220014535 | 220014864 | 1.67 | 93.2 | Palliative (P) | null | 2016-05-25 | Alemtuzumab cond (RI ALLO CAMP100) | 01 | N | 220034334 | ALEMTUZUMAB |
| 220014536 | 220009116 | 0 | 84.4 | Palliative (P) | null | 2013-06-18 | Clofarabine + Cytarabine | N | N | 220034337 | PONATINIB |
| 220014537 | 220009117 | null | 75.9 | Palliative (P) | 2017-12-07 | 2017-12-07 | Carboplatin + Etoposide iv&po | N | N | 220034342 | CARBOPLATIN + ETOPOSIDE |
| 220014538 | 220009117 | null | null | Palliative (P) | null | 2013-07-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220034342 | UKALL2014 |
| 220014539 | 220009120 | 1.65 | null | Palliative (P) | 2014-01-09 | 2014-01-11 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220034352 | CARBOPLATIN + PACLITAXEL |
| 220014540 | 220009121 | 1.73 | 68.199 | Palliative (P) | 2014-09-07 | 2014-10-04 | Cytarabine intrathecal | N | N | 220034353 | CYTARABINE INTRATHECAL |
| 220014541 | 220009122 | 1.9 | 81 | Palliative (P) | 2015-06-15 | 2015-07-11 | Fludarabine + Melphalan RIC Allo | N | N | 220034356 | GEMTUZUMAB OZOGAMICIN |
| 220014542 | 220014868 | 1.8 | 81.6 | Palliative (P) | 2017-06-28 | 2017-06-28 | IDARUBICIN | N | N | 220034364 | IDARUBICIN |
| 220014543 | 220009127 | 2 | 87.9 | Curative (C) | 2016-08-06 | 2016-08-17 | Mitox + Tretinoin Spanish Course 3 | null | null | 220034369 | MITOXANTRONE |
| 220014545 | 220009130 | null | 84.4 | Palliative (P) | 2017-07-15 | 2017-07-15 | Clofarabine + Cytarabine | N | N | 220034391 | PONATINIB |
| 220014546 | 220009131 | null | 87.8 | Palliative (P) | 2016-04-05 | 2016-05-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220034423 | CISPLATIN + GEMCITABINE |
| 220014547 | 220014871 | null | 82.4 | Palliative (P) | 2017-09-16 | 2017-10-05 | UKALL14- Ph 1 Induction | null | null | 220034424 | DOCETAXEL |
| 220014548 | 220009138 | 1.71 | 115 | Palliative (P) | 2015-06-22 | 2015-08-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220034425 | PONATINIB |
| 220014549 | 220009141 | 1.73 | 86.3 | Curative (C) | null | 2013-04-10 | METHOTREXATE | 2 | N | 220034425 | FBC |
| 220014550 | 220009141 | 1.75 | 64.8 | Palliative (P) | 2017-05-03 | 2017-09-11 | Arsenic Triox + Tretinoin Ind W5-8 | 02 | N | 220034425 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014551 | 220009143 | null | 76 | Palliative (P) | 2017-11-13 | 2017-11-13 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034436 | ALEMTUZUMAB |
| 220014552 | 220009144 | 1.6 | 51.9 | Palliative (P) | 2014-08-06 | 2014-08-20 | GEMTUZUMAB OZOGAMICIN | N | N | 220034439 | FLUDARABINE + MELPHALAN |
| 220014553 | 220009145 | 1.77 | 79 | Disease modification (D) | 2017-04-14 | 2017-04-27 | Docetaxel | N | N | 220034440 | FLUDARABINE + MELPHALAN |
| 220014554 | 220009147 | 1.79 | 67.3 | Palliative (P) | 2016-04-04 | 2016-04-20 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220034440 | DOCETAXEL |
| 220014555 | 220009149 | 1.63 | 74 | Curative (C) | 2017-08-31 | 2017-08-31 | Mitox + Tretinoin Spanish Course 3 | N | N | 220034452 | MITOXANTRONE |
| 220014556 | 220009151 | null | 78 | Palliative (P) | null | 2015-11-15 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034453 | ALEMTUZUMAB |
| 220014560 | 220009152 | 1.75 | 63.7 | Curative (C) | 2016-10-07 | 2016-10-07 | FLUDARABINE + MELPHALAN | N | N | 220034482 | DOCETAXEL |
| 220014561 | 220009155 | 1.8 | 93 | Disease modification (D) | null | 2017-07-01 | Fludarabine + Melphalan RIC Allo | N | N | 220034483 | IRINOTECAN + MDG |
| 220014562 | 220009155 | 1.63 | 77.1 | Palliative (P) | 2013-04-12 | 2013-04-29 | UKALL14- Ph 2 Induction | N | N | 220034483 | CLOFARABINE + CYTARABINE |
| 220014564 | 220009158 | 1.72 | 72.2 | Palliative (P) | 2014-07-04 | 2014-07-11 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220034495 | OXALIPLATIN + MDG |
| 220014566 | 220009166 | 1.54 | 87.7 | null | 2018-02-25 | 2018-03-04 | GEMTUZUMAB OZOGAMICIN | N | N | 220034498 | PONATINIB |
| 220014567 | 220014883 | 1.55 | 62.3 | Palliative (P) | 2013-03-12 | 2013-08-27 | Mitoxantrone | N | N | 220034505 | MITOXANTRONE |